The Protective Effect of Roflumilast Against Acute Hepatotoxicity Caused by Methotrexate in Wistar Rats: In vivo Evaluation

References

• Grigorian A, O’Brien CB. Hepatotoxicity secondary to chemotherapy. J Clin Transl Hepatol. 2014;2(2):95. doi:10.14218/JCTH.2014.00011
   PubMedGoogle Scholar
• Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem. 2018;158:502–516. doi:10.1016/j.ejmech.2018.09.027
   PubMed Web of Science ®Google Scholar
• Baughman RP, Cremers JP, Harmon M, Lower EE, Drent M. Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period. Sarcoidosis Vasculitis Diffuse Lung Dis. 2020;37(3):1.
   Web of Science ®Google Scholar
• Conway R, Carey JJ. Risk of liver disease in methotrexate treated patients. World J Hepatol. 2017;9(26):1092. doi:10.4254/wjh.v9.i26.1092
   PubMed Web of Science ®Google Scholar
• Moghadam AR, Tutunchi S, Namvaran-Abbas-Abad A, et al. Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress. BMC Complement Altern Med. 2015;15(1):1–13.
   PubMedGoogle Scholar
• Kawamatawong T. Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases. J Thorac Dis. 2017;9(4):1144. doi:10.21037/jtd.2017.03.116
   PubMed Web of Science ®Google Scholar
• Bros M, Montermann E, Cholaszczyńska A, et al. The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10. Int Immunopharmacol. 2016;35:174–184. doi:10.1016/j.intimp.2016.03.025
   PubMed Web of Science ®Google Scholar
• Kwak HJ, Song JS, No ZS, et al. The inhibitory effects of roflumilast on lipopolysaccharide-induced nitric oxide production in RAW264. 7 cells are mediated by heme oxygenase-1 and its product carbon monoxide. Inflamm Res. 2005;54(12):508–513. doi:10.1007/s00011-005-1386-1
   PubMed Web of Science ®Google Scholar
• Demiryilmaz I, Uzkeser H, Cetin N, Hacimüftüoğlu A, Bakan E, Altuner D. Effect of mirtazapine on gastric oxidative stress and DNA injury created with methotrexate in rats. Asian J Chem. 2013;25(4):1.
   Google Scholar
• Cortijo J, Iranzo A, Milara X, et al. Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin‐induced lung injury. Br J Pharmacol. 2009;156(3):534–544.
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Gamble M, editors. Theory and Practice of Histological Techniques. Elsevier health sciences; 2008.
   Google Scholar
• Erdogan E, Ilgaz Y, Gurgor PN, et al. Rutin ameliorates methotrexate induced hepatic injury in rats. Acta Cir Bras. 2015;30(11):778–784. doi:10.1590/S0102-865020150110000009
   PubMed Web of Science ®Google Scholar
• Safaei F, Mehrzadi S, Khadem Haghighian H, et al. Protective effects of gallic acid against methotrexate-induced toxicity in rats. Acta Chir Belg. 2018;118(3):152–160. doi:10.1080/00015458.2017.1394672
   PubMed Web of Science ®Google Scholar
• Bedoui Y, Guillot X, Sélambarom J, et al. Methotrexate an old drug with new tricks. Int J Mol Sci. 2019a;20(20):5023. doi:10.3390/ijms20205023
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu M, Cao Z, et al. ‘Phosphodiesterase-4 Inhibitors: A Review of Current Developments (2013–2021)’, Expert Opinion on Therapeutic Patents. Taylor & Francis, (just-accepted); 2022.
   Google Scholar
• Hatzelmann A, Morcillo EJ, Lungarella G, et al. The preclinical pharmacology of roflumilast–a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2010;23(4):235–256.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Calverley PMA, Rabe KF. Roflumilast: a review of its use in the treatment of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:81. doi:10.2147/COPD.S89849
   PubMed Web of Science ®Google Scholar
• Sanz MJ, Cortijo J, Morcillo EJ. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression. Pharmacol Ther. 2005;106(3):269–297.
   PubMed Web of Science ®Google Scholar
• Grootendorst DC, Gauw SA, Verhoosel RM, et al. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax. 2007;62(12):1081–1087.
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Boulet LP, Cockcroft DW, et al. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med. 2011;183(8):1007–1014. doi:10.1164/rccm.201008-1210OC
   PubMed Web of Science ®Google Scholar
• Schick MA, Wunder C, Wollborn J, et al. Phosphodiesterase‐4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation. J Physiol. 2012;590(11):2693–2708.
   PubMed Web of Science ®Google Scholar
• Parivar K, Rehman A, Ara J, Nahid S, Shaharyar A. Roflumilast attenuates hepatic fibrosis in carbon tetrachloride-induced experimental liver injury in rats. J Invest Med. 2012;60(4):597–604.
   Google Scholar
• Ding Y-C, Chang C-Y. Effect of roflumilast on lipopolysaccharide-induced rat liver failure. Sheng Li Xue Bao. 2017;69(4):430–436.
   Google Scholar
• Rabe KF. Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. Br J Pharmacol. 2011;163(1):53–67.
   PubMed Web of Science ®Google Scholar
• Curtis JR, Beukelman T, Onofrei A, et al. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide. Ann Rheum Dis. 2010;69(01):43–47.
   PubMed Web of Science ®Google Scholar
• Mehrzadi S, Fatemi I, Esmaeilizadeh M, et al. Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats. Biomed Pharmacother. 2018;97:233–239. doi:10.1016/j.biopha.2017.10.113
   PubMed Web of Science ®Google Scholar
• Kalantar M, Kalantari H, Goudarzi M, et al. Crocin ameliorates methotrexate-induced liver injury via inhibition of oxidative stress and inflammation in rats. Pharmacol Rep. 2019;71(4):746–752. doi:10.1016/j.pharep.2019.04.004
   PubMed Web of Science ®Google Scholar
• Feng H, Chen J, Wang H, et al. Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice. Lab Invest. 2017;97(9):1008–1019. doi:10.1038/labinvest.2017.59
   PubMed Web of Science ®Google Scholar
• Essam RM, Ahmed LA, Abdelsalam RM, et al. Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways. Life Sci. 2019;222:245–254. doi:10.1016/j.lfs.2019.03.014
   PubMed Web of Science ®Google Scholar
• Al Maruf A, O’Brien PJ, Naserzadeh P, et al. Methotrexate induced mitochondrial injury and cytochrome c release in rat liver hepatocytes. Drug Chem Toxicol. 2018;41(1):51–61. doi:10.1080/01480545.2017.1289221
   PubMed Web of Science ®Google Scholar
• Arpag H, Gül M, Aydemir Y, et al. Protective effects of alpha-lipoic acid on methotrexate-induced oxidative lung injury in rats. J Investig Surg. 2018;31(2):107–113. doi:10.1080/08941939.2017.1296513
   PubMed Web of Science ®Google Scholar
• Çetin A, Kaynar L, Kocyigit I, et al. Role of grape seed extract on methotrexate induced oxidative stress in rat liver. Am H Chin Med. 2008;36(05):861–872. doi:10.1142/S0192415X08006302
   PubMedGoogle Scholar
• Tabassum H, Parvez S, Pasha ST, et al. Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria. Food Chem Toxicol. 2010;48(7):1973–1979. doi:10.1016/j.fct.2010.04.047
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ghosh S, Choudhury S, et al. Pomegranate reverses methotrexate-induced oxidative stress and apoptosis in hepatocytes by modulating Nrf2-NF-κB pathways. J Nutr Biochem. 2013;24(12):2040–2050. doi:10.1016/j.jnutbio.2013.07.005
   PubMed Web of Science ®Google Scholar
• Spurlock CF III, Tossberg JT, Fuchs HA, et al. Methotrexate increases expression of cell cycle checkpoint genes via JNK activation. Arthritis Rheum. 2012;64(6):1780–1789. doi:10.1002/art.34342
   PubMedGoogle Scholar
• Huang W-Y, Yang P-M, Chang Y-F, et al. Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. Biochem Pharmacol. 2011;81(4):510–517. doi:10.1016/j.bcp.2010.11.014
   PubMed Web of Science ®Google Scholar
• Ehrhardt H, Häcker S, Wittmann S, et al. Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. Oncogene. 2008;27(6):783–793.
   PubMed Web of Science ®Google Scholar
• Al-Malki AL, Sayed AAR. Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa-β. BMC Complement Altern Med. 2014;14(1):1–8.
   PubMedGoogle Scholar
• Ogawa R, Streiff MB, Bugayenko A, et al. Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells. Blood J Am Soc Hematol. 2002;99(9):3390–3397.
   Google Scholar
• Schwabe RF, Brenner DA. Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol. 2006;290(4):G583–G589.
   PubMed Web of Science ®Google Scholar
• Lai W-Y, Wang J-W, Huang B-T, et al. A novel TNF-α-targeting aptamer for TNF-α-mediated acute lung injury and acute liver failure. Theranostics. 2019;9(6):1741. doi:10.7150/thno.30972
   PubMed Web of Science ®Google Scholar
• Tunalı-Akbay T, Sehirli O, Ercan F, et al. Resveratrol protects against methotrexate-induced hepatic injury in rats. J Pharm Pharm Sci. 2010;13(2):303–310. doi:10.18433/J30K5Q
   PubMed Web of Science ®Google Scholar
• Kurt A, Tumkaya L, Turut H, et al. Protective effects of infliximab on lung injury induced by methotrexate. Arch Bronconeumol. 2015;51(11):551–557. doi:10.1016/j.arbres.2015.03.018
   PubMed Web of Science ®Google Scholar
• Drishya S, Dhanisha SS, Guruvayoorappan C. Antioxidant‐rich fraction of Amomum subulatum fruits mitigates experimental methotrexate‐induced oxidative stress by regulating TNF‐α, IL‐1β, and IL‐6 proinflammatory cytokines. J Food Biochem. 2021; 2021:e13855.
   Google Scholar
• Mohamed DI, Khairy E, Tawfek SS, et al. Coenzyme Q10 attenuates lung and liver fibrosis via modulation of autophagy in methotrexate treated rat. Biomed Pharmacother. 2019;109:892–901. doi:10.1016/j.biopha.2018.10.133
   PubMed Web of Science ®Google Scholar
• El Bana E, M Kamal K. Protective and therapeutic effects of quercetin on methotrexate induced hepatotoxicity in adult albino rats: biochemical, Histological and Immunohistochemical Study. Egypt J Histol. 2020;43(1):220–229.
   Google Scholar
• De S, Sen T, Chatterjee M. Reduction of oxidative stress by an ethanolic extract of leaves of Piper betle (Paan) Linn. decreased methotrexate-induced toxicity. Mol Cell Biochem. 2015;409(1):191–197. doi:10.1007/s11010-015-2524-x
   PubMed Web of Science ®Google Scholar